HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Geranylgeraniol causes a decrease in levels of calreticulin and tyrosine phosphorylation of a 36-kDa protein prior to the appearance of apoptotic features in HL-60 cells.

Abstract
It was demonstrated recently that geranylgeraniol (GGO) has potent apoptosis-inducing activity in various lines of tumor cells, including HL-60 cells. In the present study, we found that GGO markedly inhibited the expression of a calcium-binding protein, calreticulin, prior to the induction of apoptosis in HL-60 cells. Furthermore, we also observed a significant decrease in the tyrosine phosphorylation of a 36-kDa protein that is a major tyrosine-phosphorylated protein in HL-60 cells. These findings suggest that decreases in levels of calreticulin and in the tyrosine phosphorylation of the 36-kDa protein might be associated with the induction of apoptosis by GGO in HL-60 cells.
AuthorsS Nakajo, M Okamoto, Y Masuda, I Sakai, S Ohsawa, K Nakaya
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 226 Issue 3 Pg. 741-5 (Sep 24 1996) ISSN: 0006-291X [Print] United States
PMID8831684 (Publication Type: Journal Article)
Chemical References
  • Calcium-Binding Proteins
  • Calreticulin
  • Diterpenes
  • Molecular Chaperones
  • Peptide Fragments
  • Phosphoproteins
  • RNA, Messenger
  • Ribonucleoproteins
  • Phosphotyrosine
  • geranylgeraniol
Topics
  • Amino Acid Sequence
  • Apoptosis (drug effects)
  • Calcium-Binding Proteins (biosynthesis, chemistry, metabolism)
  • Calreticulin
  • Diterpenes (pharmacology)
  • HL-60 Cells
  • Humans
  • Kinetics
  • Molecular Chaperones (metabolism)
  • Molecular Weight
  • Peptide Fragments (chemistry, isolation & purification)
  • Phosphoproteins (chemistry, isolation & purification, metabolism)
  • Phosphorylation
  • Phosphotyrosine (metabolism)
  • RNA, Messenger (biosynthesis)
  • Ribonucleoproteins (biosynthesis, chemistry, metabolism)
  • Time Factors
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: